These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23467174)

  • 1. Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience.
    Halpin SJ; Hamlin PJ; Greer DP; Warren L; Ford AC
    World J Gastroenterol; 2013 Feb; 19(7):1091-7. PubMed ID: 23467174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
    Armuzzi A; Pugliese D; Danese S; Rizzo G; Felice C; Marzo M; Andrisani G; Fiorino G; Nardone OM; De Vitis I; Papa A; Rapaccini GL; Guidi L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1368-74. PubMed ID: 24983979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of disease may predict response to infliximab in pediatric ulcerative colitis.
    Mir SA; Nagy-Szakal D; Smith EO; Gilger MA; Kellermayer R
    J Clin Gastroenterol; 2014 Mar; 48(3):248-52. PubMed ID: 24129407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience.
    Teisner AS; Ainsworth MA; Brynskov J
    Scand J Gastroenterol; 2010 Dec; 45(12):1457-63. PubMed ID: 20701434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis.
    Seah D; Choy MC; Gorelik A; Connell WR; Sparrow MP; Van Langenberg D; Hebbard G; Moore G; De Cruz P
    J Gastroenterol Hepatol; 2018 Jan; 33(1):226-231. PubMed ID: 28618062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience.
    Yamada S; Yoshino T; Matsuura M; Minami N; Toyonaga T; Honzawa Y; Tsuji Y; Nakase H
    BMC Gastroenterol; 2014 Apr; 14():80. PubMed ID: 24758588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study.
    Beswick L; Rosella O; Rosella G; Headon B; Sparrow MP; Gibson PR; van Langenberg DR
    J Crohns Colitis; 2018 Feb; 12(3):289-297. PubMed ID: 29121178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis.
    Baki E; Zwickel P; Zawierucha A; Ehehalt R; Gotthardt D; Stremmel W; Gauss A
    World J Gastroenterol; 2015 Mar; 21(11):3282-90. PubMed ID: 25805935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients.
    Angelison L; Almer S; Eriksson A; Karling P; Fagerberg U; Halfvarson J; Thörn M; Björk J; Hindorf U; Löfberg R; Bajor A; Hjortswang H; Hammarlund P; Grip O; Torp J; Marsal J; Hertervig E;
    Aliment Pharmacol Ther; 2017 Feb; 45(4):519-532. PubMed ID: 28025840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
    Nelson R; Liao C; Fichera A; Rubin DT; Pekow J
    Inflamm Bowel Dis; 2014 Jan; 20(1):14-20. PubMed ID: 24297054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis.
    Moore H; Dolce P; Devas N; Baldassano R; Martinelli M
    United European Gastroenterol J; 2020 May; 8(4):425-435. PubMed ID: 32213038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of adalimumab therapy in patients with ulcerative colitis previously treated with infliximab: a Danish single-center cohort study.
    Christensen KR; Steenholdt C; Brynskov J
    Scand J Gastroenterol; 2015 Aug; 50(8):1018-24. PubMed ID: 25861832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 10-year, single tertiary care center experience on the durability of infliximab in pediatric inflammatory bowel disease.
    Vahabnezhad E; Rabizadeh S; Dubinsky MC
    Inflamm Bowel Dis; 2014 Apr; 20(4):606-13. PubMed ID: 24552827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of infliximab treatment and predictors of response in 195 patients with ulcerative colitis: a hospital-based cohort study from Korea.
    Seo H; Chang K; Lee SH; Song EM; Kim GU; Seo M; Lee HS; Hwang SW; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yang SK; Park SH
    Scand J Gastroenterol; 2017 Aug; 52(8):857-863. PubMed ID: 28502189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients.
    Duijvis NW; Ten Hove AS; Ponsioen CI; van den Brink GR; Buskens CJ; Bemelman WA; Te Velde AA; D'Haens GR; Löwenberg M
    J Crohns Colitis; 2016 Jul; 10(7):821-7. PubMed ID: 26818660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients.
    Sjöberg M; Magnuson A; Björk J; Benoni C; Almer S; Friis-Liby I; Hertervig E; Olsson M; Karlén P; Eriksson A; Midhagen G; Carlson M; Lapidus A; Halfvarson J; Tysk C;
    Aliment Pharmacol Ther; 2013 Aug; 38(4):377-87. PubMed ID: 23799948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of early response to infliximab in patients with ulcerative colitis.
    Ferrante M; Vermeire S; Katsanos KH; Noman M; Van Assche G; Schnitzler F; Arijs I; De Hertogh G; Hoffman I; Geboes JK; Rutgeerts P
    Inflamm Bowel Dis; 2007 Feb; 13(2):123-8. PubMed ID: 17206703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab rescue therapy after cyclosporin failure in steroid-refractory ulcerative colitis.
    Mañosa M; López San Román A; Garcia-Planella E; Bastida G; Hinojosa J; Gonzalez-Lama Y; Masnou H; Domènech E
    Digestion; 2009; 80(1):30-5. PubMed ID: 19439969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.